Genentech Antibodies at ASCO
Many of Genentech’s researchers have spent years—some, their entire careers—exploring the biology of cancer and turning that into new classes of medicines. We’re very proud of that. But often what gets lost in the communication of science is the sheer passion for what we do. So this year we’re sharing it at ASCO.
May 31st, 2013- We’d like to introduce you to the Gene Antibodies. They'll be happy to pose for a pic with you at our booth (#10,005) and tell you more about the science behind them. We hope, that by sharing these, we'll be able to better explain the increasingly complex science behind our medicines.
Conventional Therapeutic Antibody
A Conventional Therapeutic Antibody is a type of cancer medicine made in a laboratory, that can identify substances on cancer cells or normal substances that may help cancer cells grow. Therapeutic antibodies used in cancer attach to the substances and kill the cancer cells, block their growth, or keep them from spreading.
Antibody Drug Conjugate
An Antibody Drug Conjugate combines an antibody with chemotherapy to deliver cancer fighting medicine directly to cancer cells.
Glycoengineered Antibody
A Glycoengineered Antibody has modified sugar molecules designed to help the immune system attack cancer cells.
Bi-specific Antibody
A Bi-specific Antibody is a “two-in-one” antibody that is designed to recognize two different targets.
One-armed Antibodies
A One-armed Antibody is a modified antibody designed to inhibit cancer cell targets that do not respond to typical two-armed antibodies.